MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2017.09.020

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2017

Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure.

Hall Shelley A, Uriel Nir, Carey Sandra A, Edens Michelle, Gong Geoffrey, Esposito Michele, O'Kelly Ryan, Annamalai Shiva, Aghili Nima, Adatya S, Kapur Navin K

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Prognosis is poor for patients with decompensated advanced heart failure (HF) refractory to medical therapy. Evaluating candidacy for durable mechanical circulatory support (MCS), cardiac transplantation, or palliative care is complex, and time is often needed to stabilize the patient hemodynamically. The Impella 5.0 (Abiomed, Danvers, MA) is a minimally invasive axial-flow catheter capable of providing full temporary hemodynamic support. We report a multicenter series on the use of this device for bridge to decision (BTD) in decompensated advanced HF patients.

METHODS

In a retrospective evaluation at 3 centers of patients with advanced HF who acutely decompensated and received the Impella 5.0 for BTD, we analyzed demographics, procedural characteristics, in-hospital and intermediate-term outcomes, and in-hospital complications.

RESULTS

There were 58 patients who met inclusion criteria from 2010 to 2015. All were inotrope dependent. The mean ejection fraction was 13%, and median age was 59 years (interquartile range, 48-64 years). Mean duration of support was 7 days (range, 0-22 days). Thirty-nine patients survived to next therapy (67%), with most receiving durable MCS (n = 20) or heart transplantation (n = 15). In-hospital complications included bleeding (n = 9) and hemolysis (n = 4). Of patients who survived to the next therapy, 1-year survival was 65% for those who received durable MCS, 87% for those who received a transplant, and 75% for those who were stabilized and weaned.

CONCLUSIONS

The Impella 5.0 may provide a BTD strategy for patients with advanced HF and acute hemodynamic instability. Prospective studies are needed to evaluate the safety and effectiveness of this device in this patient population.

Для цитирования: Hall Shelley A, Uriel Nir, Carey Sandra A, Edens Michelle, Gong Geoffrey, Esposito Michele, O'Kelly Ryan, Annamalai Shiva, Aghili Nima, Adatya S, Kapur Navin K. Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017. DOI: 10.1016/j.healun.2017.09.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.